Dr Lekh Juneja
Executive VP & Chief Health Officer - Rohto Pharmaceutical Co., Ltd.
Dr. Lekh Juneja is the Executive Vice President of Rohto Pharmaceutical Co., Ltd. Japan and serves as the Chief Health Officer (CHO) of the company as well as the Global Head of International Business and R&D. He plays a pivotal role as one of the senior board members and spearheads the global expansion of the Rohto-Mentholatum group. Dr Juneja also serves as the President of MG Pharma Inc. Osaka, Japan and Chairman of Rohto Pharma India and many other subsidiaries of Rohto group. .
Prior to joining Rohto, Dr Juneja was appointed as the Executive Vice President of Taiyo Kagaku Co., Ltd. Japan. He has also served as the Chairman of Taiyo Lucid Pvt. Ltd. India, President of Taiyo International Inc (USA), President of Taiyo Europe GmbH (Germany) and the President of Taiyo Labo Co., Ltd. Japan.
Dr. Juneja has been a board member of the International Scientific Advisory Committee of the Advanced Food Materials & Nutraceuticals Network [AFMNet, an initiative by the Canadian Government] from 2003-2011.
Throughout his extensive career, he has also authored/co-authored more than 180 research papers and three books with CRC Press. Dr. Juneja, who received his Ph.D. from Nagoya University, Japan is a prolific international speaker as well as holds over 125 patents to himself. His expertise in research, development, manufacturing, and marketing for food, cosmetics, and pharmaceuticals is recognized globally.
Dr Juneja has received various international accolades and was named as “The Fellow of the International Academy of Food Science and Technology” at the World Congress of Food Science and Technology Awards in Montreal, Canada. He was also felicitated with the prestigious “Fellow Award” by the Institute of Food Technologists (IFT) in Chicago, USA.